Citation

Gavai AV, Norris D, Delucca G, Tortolani D, Tokarski JS, Dodd D, O'Malley D, Zhao Y, Quesnelle C, Gill P, Vaccaro W, Huynh T, Ahuja V, Han WC, Mussari C, Harikrishnan L, Kamau M, Poss M, Sheriff S, Yan C, Marsilio F, Menard K, Wen ML, Rampulla R, Wu DR, Li J, Zhang H, Li P, Sun D, Yip H, Traeger SC, Zhang Y, Mathur A, Zhang H, Huang C, Yang Z, Ranasinghe A, Everlof G, Raghavan N, Tye CK, Wee S, Hunt JT, Vite G, Westhouse R, Lee FY.: Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design. J Med Chem, Volume 64 (19), 2021

Authors

Ahuja V, Delucca G, Dodd D, Everlof G, Gavai AV, Gill P, Han WC, Harikrishnan L, Huang C, Hunt JT, Huynh T, Kamau M, Lee FY., Li J, Li P, Marsilio F, Mathur A, Menard K, Mussari C, Norris D, O'Malley D, Poss M, Quesnelle C, Raghavan N, Rampulla R, Ranasinghe A, Sheriff S, Sun D, Tokarski JS, Tortolani D, Traeger SC, Tye CK, Vaccaro W, Vite G, Wee S, Wen ML, Westhouse R, Wu DR, Yan C, Yang Z, Yip H, Zhang H, Zhang Y, Zhao Y

Journal

J Med Chem

Year

2021

DOI

10.1021/acs.jmedchem.1c00625

PubMed

34543572

Machine-readable

REST APIRDF